메뉴 건너뛰기
The Lancet
Volumn 376, Issue 9754, 2010, Pages 1738-1739
HDL cholesterol and residual risk of first cardiovascular events - Authors' reply
Author keywords

[No Author keywords available]
Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN; FLUOROBENZENE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRIMIDINE DERIVATIVE; SULFONAMIDE;
EID: 78649378277     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)62132-0     Document Type: Letter
Times cited : (1)
References (7)
  • 1
    • 63649095045 scopus 로고    scopus 로고
    • Reduction in C-reactive protein and LDL cholesterol and cardiovascular events after initiation of rosuvastatin: A prospective study of the JUPITER trial
    • PM Ridker, E Danielson, FE Fonseca Reduction in C-reactive protein and LDL cholesterol and cardiovascular events after initiation of rosuvastatin: a prospective study of the JUPITER trial Lancet 373 2009 1175 1182
    • (2009) Lancet , vol.373 , pp. 1175-1182
    • Ridker, P.M.1    Danielson, E.2    Fonseca, F.E.3
  • 2
    • 34748887666 scopus 로고    scopus 로고
    • HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events
    • P Barter, AM Gotto, JC LaRosa HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events N Engl J Med 357 2007 1301 1310
    • (2007) N Engl J Med , vol.357 , pp. 1301-1310
    • Barter, P.1    Gotto, A.M.2    Larosa, J.C.3
  • 3
    • 61549120401 scopus 로고    scopus 로고
    • Prognostic utility of ApoB/A1, total cholesterol/HDL, non-HDL cholesterol, or hsCRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: Results from PROVE IT-TIMI 22
    • KK Ray, CP Cannon, R Cairns, DA Morrow, PR Ridker, E Braunwald Prognostic utility of ApoB/A1, total cholesterol/HDL, non-HDL cholesterol, or hsCRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22 Arterioscler Thromb Vasc Biol 29 2009 424 430
    • (2009) Arterioscler Thromb Vasc Biol , vol.29 , pp. 424-430
    • Ray, K.K.1    Cannon, C.P.2    Cairns, R.3    Morrow, D.A.4    Ridker, P.R.5    Braunwald, E.6
  • 4
    • 0342879940 scopus 로고    scopus 로고
    • Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/TexAs Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)
    • AM Gotto, E Whitney, EA Stein Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/TexAs Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) Circulation 101 2000 477 484
    • (2000) Circulation , vol.101 , pp. 477-484
    • Gotto, A.M.1    Whitney, E.2    Stein, E.A.3
  • 5
    • 0037066048 scopus 로고    scopus 로고
    • Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial
    • JR Simes, IC Marschner, D Hunet Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial Circulation 105 2002 1162 1169
    • (2002) Circulation , vol.105 , pp. 1162-1169
    • Simes, J.R.1    Marschner, I.C.2    Hunet, D.3
  • 6
    • 0032554688 scopus 로고    scopus 로고
    • Relationship between plasma LDL concentration during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events Trial
    • FM Sacks, LA Moye, BR Davis Relationship between plasma LDL concentration during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events Trial Circulation 97 1998 1446 1452
    • (1998) Circulation , vol.97 , pp. 1446-1452
    • Sacks, F.M.1    Moye, L.A.2    Davis, B.R.3
  • 7
    • 0032554686 scopus 로고    scopus 로고
    • Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study
    • TR Pedersen, AG Olsson, O Faergemann Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study Circulation 97 1998 1453 1460
    • (1998) Circulation , vol.97 , pp. 1453-1460
    • Pedersen, T.R.1    Olsson, A.G.2    Faergemann, O.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.